Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

作者: Jessica Williams , William N Steers , Susan L Ettner , Carol M Mangione , Obidiugwu K Duru

DOI: 10.1097/MLR.0B013E318270DC52

关键词:

摘要: Only about 50% of patients with chronic conditions routinely take their medicine as directed [1]. Diabetic patients’ nonadherence to medication is associated adverse health outcomes, including increased hospitalization rates and higher mortality [2-6]. Patients report many reasons for such forgetfulness, desire avoid side effects, the relatively high costs some medications [2]. Efforts increase overall adherence often focus specifically on decreasing cost-related because it common can be addressed policy-based approaches. Cost-related (CRN) among older adults has been documented prior initiation Medicare Part D program remains a significant problem, recent published estimates CRN ranging from 13% 36% [7-10]. The existing research somewhat limited, vast majority papers examining have used administrative data calculate adherence, rather than direct patient report. Most these also observed responses cost sharing changes in copayment or prescription tiering strategies, infer indirectly that out pocket [11-16]. Some authors found people are more likely cut back they consider “less” necessary which an over-the-counter substitution readily available [17-18]. However, while other studies directly asked types use less due (e.g., anti-hypertensives, cholesterol-lowering medications), shows do not fact know indication all [19]. Few reconciled pharmacy actual bottles patient’s possession determine adults. Using collected part Translating Research into Action Diabetes (TRIAD) Study, main objective this analysis examine rate self-reported population persons diabetes who entered coverage gap 2006. Data were obtained during telephone interviews bring phone, self-report any currently taking. In group elderly beneficiaries diabetes, we hypothesized would treating (diabetes, blood pressure, cholesterol) primarily symptom relief. We simultaneously investigated possibility beneficiaries’ socio-demographic characteristics. In particular, having income will make after controlling factors.

参考文章(36)
Steven M. Teutsch, XiaoFeng Liu, PharmD Winnie Yu, and Marc L. Berger, Pamela B. Landsman, Mph, DrPH, Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. The American Journal of Managed Care. ,vol. 11, pp. 621- 628 ,(2005)
Motheral Br, Henderson R, The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation The American Journal of Managed Care. ,vol. 5, pp. 1383- ,(1999)
Annette N. Pellegrino, Michelle T. Martin, Jessica J. Tilton, Daniel R. Touchette, Medication therapy management services: definitions and outcomes. Drugs. ,vol. 69, pp. 393- 406 ,(2009) , 10.2165/00003495-200969040-00001
Michael B. Eldredge, Richard E. Johnson, Michael J. Goodman, Mark C. Hornbrook, The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Services Research. ,vol. 32, pp. 103- 122 ,(1997)
O Kenrik Duru, Carol M Mangione, John Hsu, W Neil Steers, Elaine Quiter, Norman Turk, Susan L Ettner, Julie A Schmittdiel, Chien‐Wen Tseng, None, Generic‐Only Drug Coverage in the Medicare Part D Gap and Effect on Medication Cost‐Cutting Behaviors for Patients with Diabetes Mellitus: The Translating Research into Action for Diabetes Study Journal of the American Geriatrics Society. ,vol. 58, pp. 822- 828 ,(2010) , 10.1111/J.1532-5415.2010.02813.X
Kara Zivin Bambauer, Dana Gelb Safran, Dennis Ross-Degnan, Fang Zhang, Alyce S. Adams, Jerry Gurwitz, Marsha Pierre-Jacques, Stephen B. Soumerai, Depression and Cost-Related Medication Nonadherence in Medicare Beneficiaries Archives of General Psychiatry. ,vol. 64, pp. 602- 608 ,(2007) , 10.1001/ARCHPSYC.64.5.602
Dana P Goldman, Geoffrey F Joyce, Jose J Escarce, Jennifer E Pace, Matthew D Solomon, Marianne Laouri, Pamela B Landsman, Steven M Teutsch, Pharmacy Benefits and the Use of Drugs by the Chronically Ill JAMA. ,vol. 291, pp. 2344- 2350 ,(2004) , 10.1001/JAMA.291.19.2344